- Home
- QNTM vs RVYL Comparison
QNTM vs RVYL Comparison
Compare QNTM & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNTM
- RVYL
- Stock Information
- Founded
- QNTM 1998
- RVYL 2007
- Country
- QNTM Canada
- RVYL United States
- Employees
- QNTM N/A
- RVYL N/A
- Industry
- QNTM
- RVYL Professional Services
- Sector
- QNTM
- RVYL Consumer Discretionary
- Exchange
- QNTM NYSE
- RVYL Nasdaq
- Market Cap
- QNTM 9.1M
- RVYL 10.4M
- IPO Year
- QNTM N/A
- RVYL N/A
- Fundamental
- Price
- QNTM $3.42
- RVYL $1.40
- Analyst Decision
- QNTM
- RVYL Hold
- Analyst Count
- QNTM 0
- RVYL 1
- Target Price
- QNTM N/A
- RVYL N/A
- AVG Volume (30 Days)
- QNTM 223.5K
- RVYL 101.1K
- Earning Date
- QNTM 01-28-2025
- RVYL 11-14-2024
- Dividend Yield
- QNTM N/A
- RVYL N/A
- EPS Growth
- QNTM N/A
- RVYL N/A
- EPS
- QNTM N/A
- RVYL N/A
- Revenue
- QNTM N/A
- RVYL $63,529,000.00
- Revenue This Year
- QNTM N/A
- RVYL N/A
- Revenue Next Year
- QNTM N/A
- RVYL $48.92
- P/E Ratio
- QNTM N/A
- RVYL N/A
- Revenue Growth
- QNTM N/A
- RVYL 16.09
- 52 Week Low
- QNTM $2.70
- RVYL $0.89
- 52 Week High
- QNTM $70.85
- RVYL $4.85
- Technical
- Relative Strength Index (RSI)
- QNTM 41.28
- RVYL 49.24
- Support Level
- QNTM $3.20
- RVYL $1.30
- Resistance Level
- QNTM $3.55
- RVYL $1.44
- Average True Range (ATR)
- QNTM 0.43
- RVYL 0.15
- MACD
- QNTM -0.00
- RVYL -0.00
- Stochastic Oscillator
- QNTM 14.97
- RVYL 19.35
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.